NEUREN PHARMACEUTICALS LIMITED
Markets News
Markets
FMA to focus on private market offers
The FMA is worried about unsophisticated investors taking the bait.
Markets
Xero splashes $4.1b for 'step-change' US acquisition
Buying Melio gives Xero a leg-up in the crucial US SME market.
Infrastructure
Chorus broadband expansion makes priority list
Chorus claims $17 billion NZ Inc gain for a $3b spend.
Markets
Fletcher Building’s FY result won’t be pretty
No dividends will be paid until the debt target is met.
Primary Sector
Iran conflict underscores dairy’s early-season risk warnings
The Israel-Iran war raises logistics risks for dairy but prices likely to remain steady.
